[Acute myocardial infarction in young persons. Risk factors and coronariographic study]. 1985

L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí

UI MeSH Term Description Entries
D008297 Male Males
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
January 2023, Georgian medical news,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
January 2011, Journal of Ayub Medical College, Abbottabad : JAMC,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
October 2022, Laeknabladid,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
February 1990, Klinicheskaia meditsina,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
January 1989, Indian heart journal,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
January 2009, The Journal of invasive cardiology,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
August 2006, Annales de cardiologie et d'angeiologie,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
April 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
January 1993, Trends in cardiovascular medicine,
L Martín Jadraque, and M Acosta Varo, and I González Maqueda, and J L López-Sendón, and F Ortuño Aznar, and I Coma Canella, and F García Fernández, and J Muñoz del Moral, and N Sobrino Daza, and J Sotillo Martí
January 1991, Archivos del Instituto de Cardiologia de Mexico,
Copied contents to your clipboard!